No Data
No Data
Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients
Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adul
More Unpleasant Surprises Could Be In Store For Veru Inc.'s (NASDAQ:VERU) Shares After Tumbling 39%
Veru Inc. (NASDAQ:VERU) shares have retraced a considerable 39% in the last month, reversing a fair amount of their solid recent performance. Instead of being rewarded, shareholders who have alread
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
Veru Inc. (NASDAQ: VERU) today announced that its Annual Meeting of Shareholders scheduled for today (Annual Meeting) was convened and adjourned without any business being conducted due to lack of a required quorum.
Warning! US experts are concerned that if the bird flu virus mutates and evolves, a pandemic may occur.
This round of bird flu transmission has the characteristic of wide spread and extremely strong infectivity. At present, apart from Australia, relevant cases have been reported in other continents around the world. In addition to livestock, there have been several cases of human infection with avian flu virus this year, which has greatly alarmed the academic community. Former director of the US Centers for Disease Control and Prevention warned that humans may face a pandemic of bird flu.
The world's first non-COVID-19 mRNA vaccine has been approved! The market is a blue ocean. Can the RSV newcomer make a comeback?
① A "newcomer" has entered the multi-billion dollar RSV vaccine market, and it is also the world's first non-COVID mRNA vaccine approved. ② Analysis shows that whether it is recombinant protein vaccine or mRNA vaccine, which technology route can better meet clinical needs in the future will be the key evaluation. ③ The advantage of the mRNA vaccine lies in its low cost and fast R&D and production.
Russell 3000: Veru, Life MD Among Consumer Staple Additions; Benson Hill, PetMed Express Among Deletions